Imago BioSciences, Inc. Increase (Decrease) in Accounts Payable
Imago BioSciences, Inc. reported Increase (Decrease) in Accounts Payable of $439.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2022-11-09
- Imago BioSciences, Inc. increase (decrease) in accounts payable for the quarter ending 2022-09-30 was $1.31M.
- Imago BioSciences, Inc. increase (decrease) in accounts payable for the quarter ending 2022-06-30 was -$741.00K.
- Imago BioSciences, Inc. increase (decrease) in accounts payable for the quarter ending 2022-03-31 was -$134.00K, a 109.65% decline year-over-year.
- Imago BioSciences, Inc. increase (decrease) in accounts payable for the quarter ending 2021-12-31 was $1.56M, a 355.10% increase year-over-year.
- Imago BioSciences, Inc. increase (decrease) in accounts payable for fiscal 2021 was $2.06M, a 25675.00% increase from fiscal 2020.
- Imago BioSciences, Inc. increase (decrease) in accounts payable for fiscal 2020 was $8.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $573.00K derived: sum of 2 quarters · filed 2022-11-09 | $439.00K 10-Q · filed 2022-11-09 | $2.00M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | -$741.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$875.00K 10-Q · filed 2022-08-12 | $686.00K derived: sum of 3 quarters · filed 2022-08-12 | $602.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-03-31 | -$134.00K 10-Q · filed 2022-05-12 | $1.43M derived: sum of 2 quarters · filed 2022-05-12 | $1.34M derived: sum of 3 quarters · filed 2022-11-09 | $539.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $1.48M derived: sum of 2 quarters · filed 2022-11-09 | $673.00K derived: sum of 3 quarters · filed 2022-11-09 | $2.06M 10-K · filed 2022-03-24 |
| 2021-09-30 | -$84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$888.00K derived: sum of 2 quarters · filed 2022-11-09 | $501.00K 10-Q · filed 2022-11-09 | $844.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$804.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $585.00K 10-Q · filed 2022-08-12 | $928.00K derived: sum of 3 quarters · filed 2022-08-12 | -$230.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $1.39M 10-Q · filed 2022-05-12 | $1.73M derived: sum of 2 quarters · filed 2022-05-12 | $574.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $343.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$815.00K derived: sum of 2 quarters · filed 2022-03-24 | $8.00K 10-K · filed 2022-03-24 | |
| 2020-09-30 | -$1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$335.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $823.00K 10-Q · filed 2021-08-19 |